Screening of these RNA-seq data demonstrated prominent MKX expression in AML cell line OCI-AML3, low levels in multiple myeloma (MM) cell lines KMM-1, L-363, LP-1 and OPM-2, while cell lines derived from other entities including BCP-ALL tested negative (Fig 1A). This evidence concerns the gene MKX and Miyoshi myopathy.